Website: https://www.lmu-klinikum.de/tropeninstitut
Imprint: https://www.lmu-klinikum.de/imprint?homepage=82c56d5e66569cbf
Learn more about the TB Sequel project: www.tbsequel.org
Photo (c) TB Sequel Project
Learn more about the TB Sequel project: www.tbsequel.org
Photo (c) TB Sequel Project
Visit us on LinkedIn for a Day 1 Summary: www.linkedin.com/posts/tropen...
Visit us on LinkedIn for a Day 1 Summary: www.linkedin.com/posts/tropen...
badw.de/die-akademie...
Foto: StMWK/Axel König
badw.de/die-akademie...
Foto: StMWK/Axel König
👉 Read more in our news: t1p.de/gkjvc
@ulrike-protzer.bsky.social @tum.de
#Virology #TherVacB #HepatitisB
👉 Read more in our news: t1p.de/gkjvc
@ulrike-protzer.bsky.social @tum.de
#Virology #TherVacB #HepatitisB
👉Read more: t1p.de/5wthc
#AIinMedicine #DigitalHuman #PrecisionMedicine
👉Read more: t1p.de/5wthc
#AIinMedicine #DigitalHuman #PrecisionMedicine
Tillotts Pharma GmbH veranstaltet ein Netzwerk-Event speziell für euch:
📅 Mittwoch, 26. November 2025
🕟 18:30 Uhr
📍 Courtyard by Marriott Düsseldorf Hafen
Speditionstraße 11, 40221 Düsseldorf
#CDifficile #Vernetzung #Frauenkarrieren #Tillotts
Tillotts Pharma GmbH veranstaltet ein Netzwerk-Event speziell für euch:
📅 Mittwoch, 26. November 2025
🕟 18:30 Uhr
📍 Courtyard by Marriott Düsseldorf Hafen
Speditionstraße 11, 40221 Düsseldorf
#CDifficile #Vernetzung #Frauenkarrieren #Tillotts
At the World Health Summit, experts discussed new incentive strategies to advance new antimicrobial therapies. Their call: Antibiotic development must be treated as critical infrastructure t1p.de/c1l3n
At the World Health Summit, experts discussed new incentive strategies to advance new antimicrobial therapies. Their call: Antibiotic development must be treated as critical infrastructure t1p.de/c1l3n
Find out more: www.lmu-klinikum.de/cih-lmu/educ...
Find out more: www.lmu-klinikum.de/cih-lmu/educ...
🚀Apply for junior group leader positions in our HUMAN program by November 26.
www.helmholtz-hzi.de/en/career/jo...
www.helmholtz-hzi.de/en/career/jo...
🚀Apply for junior group leader positions in our HUMAN program by November 26.
www.helmholtz-hzi.de/en/career/jo...
www.helmholtz-hzi.de/en/career/jo...
www.lmu-klinikum.de/tropeninstit...
#Grippe #Influenza #Impfung #Forschung
www.lmu-klinikum.de/tropeninstit...
#Grippe #Influenza #Impfung #Forschung
👉 Don’t miss out and submit your abstract here: : dzif-peg-annual-meeting.de/programme-ab...
👉 Don’t miss out and submit your abstract here: : dzif-peg-annual-meeting.de/programme-ab...
Further details & contact to the organizing team:
www.cih.lmu.de/events/2026/...
Further details & contact to the organizing team:
www.cih.lmu.de/events/2026/...
👉 Apply now and learn more about the award: www.dzif.de/en/apply-now...
👉 Apply now and learn more about the award: www.dzif.de/en/apply-now...
🗓 Abstract deadline: Aug 15, 2025 | Poster: Sept 30, 2025
🎟 Submit, register & book now:
👉 dzif-peg-annual-meeting.de
#InfectionResearch #DZIF #PEG2026
🗓 Abstract deadline: Aug 15, 2025 | Poster: Sept 30, 2025
🎟 Submit, register & book now:
👉 dzif-peg-annual-meeting.de
#InfectionResearch #DZIF #PEG2026
Mehr Infos: www.leibniz-liv.de/aktuelles/ne...
@dzif.bsky.social @leibniz-gemeinschaft.de
Bild ©Adobe Stock, MingQi
Mehr Infos: www.leibniz-liv.de/aktuelles/ne...
@dzif.bsky.social @leibniz-gemeinschaft.de
Bild ©Adobe Stock, MingQi
Die Kampagne „Aufklärung zu #HDV & #HBV“ von #TherVacB & #DSOLVE erklärt Co-Infektion, Diagnose und Therapie in Videos mit Expertinnen & Patientenperspektiven⚕️
📺 Zur Videoreihe: tinyurl.com/HepatitisBDW...
#WHT2025 #HepSky
Die Kampagne „Aufklärung zu #HDV & #HBV“ von #TherVacB & #DSOLVE erklärt Co-Infektion, Diagnose und Therapie in Videos mit Expertinnen & Patientenperspektiven⚕️
📺 Zur Videoreihe: tinyurl.com/HepatitisBDW...
#WHT2025 #HepSky
#TherVacB, a new therapeutic vaccine for chronic hepatitis B from #HelmholtzMunich, starts phase 1b/2a trial in patients. It aims to boost the immune system to eliminate the virus.
👉 t1p.de/qcncm
@lmu-klinikum.bsky.social @tum.de @ulrike-protzer.bsky.social
#TherVacB, a new therapeutic vaccine for chronic hepatitis B from #HelmholtzMunich, starts phase 1b/2a trial in patients. It aims to boost the immune system to eliminate the virus.
👉 t1p.de/qcncm
@lmu-klinikum.bsky.social @tum.de @ulrike-protzer.bsky.social
👉 www.dzif.de/en/therapeut... 👉 @thervacb-eu.bsky.social
👉 www.dzif.de/en/therapeut... 👉 @thervacb-eu.bsky.social
Wednesday, 10 September 2025
14:00–15:00 SAST
#Tuberculosis #PTLD
Wednesday, 10 September 2025
14:00–15:00 SAST
#Tuberculosis #PTLD